Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Australian and New Zealand Journal of Public Health|September 11, 2008
Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical careColin Luke, Bogda Koczwara, Christos Karapetis, et al.
European Urology Oncology|July 7, 2019
A Single Educational Seminar Increases Confidence and Decreases Dropout from Active Surveillance by 5 Years After Diagnosis of Prostate CancerNetty Kinsella, Kerri Beckmann, Declan Cahill, et al.
European Urology|December 1, 2018
Androgen Deprivation Therapies and Changes in Comorbidity: A Comparison of Gonadotropin-releasing Hormone Agonists and Antiandrogen Monotherapy as Primary Therapy in Men with High-risk Prostate CancerKerri Beckmann, Hans Garmo, Jan Adolfsson, et al.
Cancers|November 13, 2021
Serum Total Bilirubin and Risk of Cancer: A Swedish Cohort Study and Meta-AnalysisMaria J Monroy-Iglesias, Charlotte Moss, Kerri Beckmann, et al.
BMC Cancer|June 23, 2019
Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control studyKerri Beckmann, Beth Russell, Debra Josephs, et al.
Cancers|October 16, 2025
Cancer Burden Attributable to Potentially Modifiable Risk Factors in AustraliaTenaw Tiruye, Bereket Duko, Laychiluh Mekonnen, et al.
BMC Urology|August 7, 2019
Is there any association between prostate-specific antigen screening frequency and uptake of active surveillance in men with low or very low risk prostate cancer?Kerri Beckmann, Netty Kinsella, Henrik Olsson, et al.
BMC Cancer|May 20, 2021
Guy's and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance databaseSalonee Shah, Kerri Beckmann, Mieke Van Hemelrijck, et al.
Frontiers in Oncology|November 2, 2020
Use of Warfarin or Direct Oral Anticoagulants and Risk of Prostate Cancer in PCBaSe: A Nationwide Case-Control StudyJonathan Parker, Danielle Crawley, Hans Garmo, et al.
Clinical Genitourinary Cancer|February 18, 2024
Medication-based Comorbidity Measures and Prostate Cancer Treatment SelectionTenaw Tiruye, Michael O'Callaghan, Liesel M FitzGerald, et al.
Pageof 9